Fulgent Genetics (FLGT) Equity Income (2017 - 2020)
Fulgent Genetics' (FLGT) quarterly Equity Income came in at $143000.0 in Q4 2020, up 182.18% year-over-year from $50676.2 in Q1 2020, and up 175.66% quarter-over-quarter from -$189000.0 in Q3 2020.
Analysis
Fulgent Genetics (FLGT) Equity Income (2017 - 2020) Analysis & Trends
Fulgent Genetics has disclosed Equity Income across 4 years of filings, most recently posting $143000.0 for Q4 2020.
- In Q4 2020, Equity Income rose 182.18% year-over-year to $143000.0; the TTM figure through Dec 2020 stood at -$488000.0 (up 37.19% YoY), while the FY2020 annual figure was -$488000.0, up 37.19% from the prior year.
- Equity Income came in at $143000.0 for Q4 2020 at Fulgent Genetics, up from -$189000.0 in the prior quarter.
- In the past five years, Equity Income ranged from a high of $143000.0 in Q4 2020 to a low of -$279000.0 in Q1 2019.
- Average Equity Income over 4 years is -$181600.0, with a median of -$193000.0 recorded in 2020.
- Year-over-year, Equity Income sank 134.29% in 2018 and soared 182.18% in 2020.
- Over 4 years, Equity Income stood at -$247000.0 in 2017, then increased by 5.26% to -$234000.0 in 2018, then climbed by 25.64% to -$174000.0 in 2019, then soared by 182.18% to $143000.0 in 2020.
- Per Business Quant data, the three most recent Equity Income figures were $143000.0 in Q4 2020, -$189000.0 in Q3 2020, and -$193000.0 in Q2 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 10.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | -6.20 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | -2.86 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | - |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 143,000.00 |
| Sep 30, 2020 | -189,000.00 |
| Jun 30, 2020 | -193,000.00 |
| Mar 31, 2020 | -249,000.00 |
| Dec 31, 2019 | -174,000.00 |
| Sep 30, 2019 | -175,000.00 |
| Jun 30, 2019 | -149,000.00 |
| Mar 31, 2019 | -279,000.00 |
| Dec 31, 2018 | -234,000.00 |
| Sep 30, 2018 | -210,000.00 |
| Jun 30, 2018 | -246,000.00 |
| Mar 31, 2018 | -245,000.00 |
| Dec 31, 2017 | -247,000.00 |
| Sep 30, 2017 | -172,000.00 |
| Jun 30, 2017 | -105,000.00 |